Between 2019 and 2023, prescriptions for nasal spray formulations increased from 4% to 48%, those for glucagon autoinjectors increased by 18%, and those for unmixed syringes dipped from 96% to 31% ...

According to McCulloch, Xeris is the only glucagon company “out there advocating for the new guidelines and promoting in the space.” Amphastar's intranasal glucagon dry powder, Baqsimi ...

Medications delivered by such a means include fentanyl transmucosal lozenges, sublingual nitroglycerin, and intranasal DDAVP ... topical anesthetics, glucagon for hypoglycemia, and agents for ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as ... Giving the drug by subcutaneous or intramuscular injection requires training however as it needs to be mixed in a ...

The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors  and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a ...

Veiga-Fernandes and colleagues reported on their findings in Science, in a paper titled “Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis.” In their report the ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

I'm a single 35-year-old woman who doesn't want to have kids. Among many of life's uncertainties, knowing that I want to stay child-free has been both clarifying and freeing. I also don't take for ...